2023-08-04T19:51:47+03:00[Europe/Moscow] en true <p>enoxaparin, dalteparin</p>, <p>-ban suffix + fondaparinux </p>, <p>dabigatran/ pradaxa </p>, <p>warfarin</p>, <p>alteplase, tenecteplase, reteplase, streptokinase </p>, <p>1 mg/kg SQ BID; renal dose 1mg/kg sq o.d.</p>, <p>200 IU/kg o.d.</p>, <p>parental overlap for 5 days + 150 mg po BID</p>, <p>15 mg po BID x 21 days; 20 mg po o.d.; may lower to 10 mg po o.d.; no parenteral overlap</p>, <p>10 mg po BID x 7 days; 5 mg po BID; may lower to 2.5 mg po BID after 6 months; no parenteral overlap</p>, <p>Parenteral overlap for 5 days + 60 mg daily</p>, <p>d</p>, <p>a, d</p> flashcards
DVT/PE drug class

DVT/PE drug class

  • enoxaparin, dalteparin

    What are our Low MW Heparins? (2)

  • -ban suffix + fondaparinux

    What are our Factor Xa inhibitors?

  • dabigatran/ pradaxa

    What is our direct thrombin inhibitor?

  • warfarin

    What is our Vitamin K antagonist?

  • alteplase, tenecteplase, reteplase, streptokinase

    What are our thrombolytics? (4)

  • 1 mg/kg SQ BID; renal dose 1mg/kg sq o.d.

    Explain Enoxaparin Venous ThromboEmbolism dosing.

  • 200 IU/kg o.d.

    Explain Dalteparin VTE dosing.

  • parental overlap for 5 days + 150 mg po BID

    Explain Dabigatran VTE dosing.

  • 15 mg po BID x 21 days; 20 mg po o.d.; may lower to 10 mg po o.d.; no parenteral overlap

    Explain Rivaroxaban VTE dosing.

  • 10 mg po BID x 7 days; 5 mg po BID; may lower to 2.5 mg po BID after 6 months; no parenteral overlap

    Explain Apixaban VTE dosing.

  • Parenteral overlap for 5 days + 60 mg daily

    Explain Edoxaban VTE dosing.

  • d

    Which has no dose adjustments?

    a) dabigatran

    b) rivaroxaban

    c) apixaban

    d) edoxaban

    e) enoxaparin

  • a, d

    Which has parenteral overlap?

    a) dabigatran

    b) rivaroxaban

    c) apixaban

    d) edoxaban

    e) enoxaparin